ExLibris header image
SFX Logo
Title: Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer’s Disease
Source:

Journal of Medicinal Chemistry [0022-2623] Jole Fiorito, Jeremie yr:2017


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease." Journal of Alzheimer's disease. 52.1: 295-302. Link to SFX for this item
2. Fà, M. "Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease." Journal of Alzheimer's disease 49.3 (2015): 707-721. Link to SFX for this item
3. Roy, Saktimayee M. "Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models." ACS chemical neuroscience 6.4 (2015): 666-680. Link to Full Text for this item Link to SFX for this item
4. Bezprozvanny, I. "Restoring calcium homeostasis to treat Alzheimer's disease: a future perspective." Neurodegenerative Disease Management 5.5 (2015): 395-8. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced